Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 5:20:e20200170.
doi: 10.1590/1677-5449.200170. eCollection 2021.

Vascular involvement in Behçet's disease: the immunopathological process

Affiliations
Review

Vascular involvement in Behçet's disease: the immunopathological process

Raquelle Machado de Vargas et al. J Vasc Bras. .

Abstract

Behçet's disease is a rare form of systemic vasculitis that affects small to large vessels. It is characterized by mucocutaneous, pulmonary, cardiovascular, gastrointestinal, and neurological manifestations. Its clinical presentation is quite wide, ranging from milder cases to severe cases, with multisystemic involvement, characteristically with exacerbations and remissions. Its etiopathogenesis is still unclear, although there is evidence of genetic, environmental, and immunological factors, such as the association with the HLA-B51 allele. In conjunction, all of these point to an abnormal immunopathological process, with activation of cells of innate and adaptive immunity, such as NK cells, neutrophils, and T cells, which generate specific response patterns and cytokines capable of generating mediators that can damage and inflame blood vessels, resulting in venous and arterial occlusions and/or aneurysm formation.

Resumo: A doença de Behçet constitui uma forma rara de vasculite sistêmica, que acomete de pequenos a grandes vasos. É caracterizada por manifestações mucocutâneas, pulmonares, cardiovasculares, gastrointestinais e neurológicas. Sua apresentação clínica é bastante ampla, variando de casos mais brandos a casos graves, com acometimento multissistêmico, caracteristicamente com exacerbações e remissões. Suas causas ainda são desconhecidas; entretanto, há evidências genéticas, ambientais e imunológicas, como a associação com o alelo HLA-B51. Todas essas, em conjunto, apontam para um processo imunopatológico anormal, com ativação de células da imunidade inata e adaptativa, como as células natural killer, neutrófilos e células T, que geram padrões de respostas e citocinas específicos capazes de gerar mediadores que podem lesionar e inflamar o sistema vascular, resultando em oclusões venosas, arteriais e/ou formação de aneurismas.

Keywords: Behçet syndrome; HLA-B51 antigen; systemic vasculitis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: No conflicts of interest declared concerning the publication of this article.

Figures

Figure 1
Figure 1. Flow diagram illustrating selection of articles.
Figure 2
Figure 2. Diagram illustrating the immunopathological mechanism of Behçet’s disease. The HLA-B51 allele and infections mediate pathogenesis of Behçet’s disease. These triggers inappropriately activate an immune system capable of producing cytokines and, consequently, reactive cells, injuring vessels as a consequence. IL = interleukin; IFN = interferon; TNF = tumor necrosis factor.
Figura 1
Figura 1. Fluxograma de seleção de artigos.
Figura 2
Figura 2. Diagrama do mecanismo imunopatológico da doença de Behçet - o alelo HLA-B51 associado às infecções medeiam a patogenia da doença de Behçet. Tais gatilhos ativam um sistema imunológico inadequadamente capazes de produzir citocinas e, consequentemente, células reativas, lesionando, por fim, os vasos. IL = interleucina; IFN = interferon; TNF = fator de necrose tumoral.

References

    1. Neves FS, Moraes JC, Gonçalves CR. Síndrome de Behçet: à procura de evidências. Rev Bras Reumatol. 2006;46(Supl. 1):21–29. doi: 10.1590/S0482-50042006000700005. - DOI
    1. Ferrão C, Almeida I, Marinho A, Vasconcelos C, Correia JA. A nossa regra de ouro na doença de Behçet: tratar a manifestação clínica. Arq Med. 2015;29(3):75–79.
    1. Erkan F, Gül A, Tasali E. Pulmonary manifestations of Behçet’s disease. Thorax. 2001;56(7):572–578. doi: 10.1136/thorax.56.7.572. - DOI - PMC - PubMed
    1. Yuan S-M. Pulmonary artery aneurysms in Behçet disease. J Vasc Bras. 2014;13(3):217–228. doi: 10.1590/jvb.2014.041. - DOI
    1. Seyahi E, Yurdakul S. Behçet’s Syndrome and thrombosis. Mediterr J Hematol Infect Dis. 2011;3(1):e2011026. doi: 10.4084/mjhid.2011.026. - DOI - PMC - PubMed

LinkOut - more resources